FDA authorizes updated Pfizer and Moderna COVID-19 boosters

On Wednesday, the U.S. Food and Drug Administration (FDA) amended the emergency use authorizations of the updated Moderna and Pfizer COVID-19 vaccine booster shots. Both are bivalent formulations of the vaccines for use as a single booster dose at least two months following primary or booster vaccination. The bivalent vaccines, … Continue reading FDA authorizes updated Pfizer and Moderna COVID-19 boosters